Erythropoietin for Management of Anemia Caused by Chemotherapy
NCT02890602
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG:
Darbepoetin alfa
DRUG:
R-CHOP
Sponsor
Kosin University Gospel Hospital